3,4-dihydroxyphenylacetic acid has been researched along with niacinamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedetti, MS; Keane, PE | 1 |
| Aguirre, N; Hervías, I; Lasheras, B | 1 |
| Anderson, DW; Bradbury, KA; Schneider, JS | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and niacinamide
| Article | Year |
|---|---|
Niaprazine, a selective brain catecholamine depletor.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Catecholamines; Depression, Chemical; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Niacinamide; Piperazines; Rats; Reserpine; Serotonin; Tetrabenazine; Time Factors | 1979 |
2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Animals; Body Temperature; Brain; Carrier Proteins; Corpus Striatum; Dopamine; Drug Synergism; Frontal Lobe; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothermia; Male; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurotoxins; Niacinamide; Organ Specificity; Paroxetine; Rats; Rats, Wistar; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2000 |
Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Humans; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Niacinamide; Oxidative Stress; Parkinsonian Disorders; Tyrosine 3-Monooxygenase; Vitamin B Complex | 2008 |